professor, The Affiliated Cancer Hospital of Nanjing Medical University, China.
Yang Liu is a Chief Physician and Associate Professor specializing in colorectal surgery. With expertise in minimally invasive and robotic surgeries, he performs over 150 advanced procedures annually. His contributions to medical research and patient care make him a key figure in the field of colorectal cancer treatment.
Profile
Scopus
Education
Yang Liu has undergone rigorous medical training, culminating in his position as a Chief Physician. He is an accomplished researcher and associate professor, continuously contributing to the development of colorectal cancer treatments.
Experience
Yang Liu is known for his extensive experience in colorectal surgery, with a focus on complex minimally invasive and robotic procedures. His surgical expertise, combined with his research on cancer genomics, has solidified his reputation in both clinical practice and academic settings.
Research Interests
Yang Liu’s research primarily focuses on the role of non-coding RNA (ncRNA) in colorectal cancer progression and metastasis. He is involved in various projects exploring epigenetic mechanisms and targeted therapies for colorectal cancer. His goal is to advance the understanding and treatment of this complex disease.
Awards
Publications
- Multi-Dimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer
- LUCAT1 inhibits ferroptosis in bladder cancer by regulating STAT3 mRNA stability
- Silver nanoparticles induce apoptosis and non-canonical autophagy in HT-29 colon cancer cells
- Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer
Conclusion
Yang Liu stands out as a strong candidate for the Best Researcher Award due to his significant clinical expertise, impactful research contributions, and innovation in medical technology. His leadership in colorectal surgery and mentorship roles, combined with a growing portfolio of high-impact publications and patents, underscore his potential for making groundbreaking advances in cancer treatment. To further enhance his candidacy, he could focus on increasing his international presence and broadening his research scope. Nonetheless, his accomplishments to date make him a highly competitive candidate for the award.